Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PMS-ZIPRASIDONE DIN 02478838

Status: Cancelled Pre Market
Holder: PHARMASCIENCE INC
Molecule: ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)

Health Canada record

Active ingredient(s)ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN05AE04 ZIPRASIDONE
Original market date
Current status date31-Jul-2026
SourceHealth Canada DPD

Establishment licence of the holder

Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)

DINProductCompanyFormStrengthStatus
02449544AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGMarketed
02449579AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGMarketed
02449560AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGMarketed
02449552AURO-ZIPRASIDONEAURO PHARMA INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGMarketed
02298600ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGMarketed
02298597ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGMarketed
02298619ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGMarketed
02298627ZELDOXBGP PHARMA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGMarketed
02441365GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGCancelled Pre Market
02441357GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGCancelled Pre Market
02441373GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGCancelled Pre Market
02441381GD-ZIPRASIDONEGENMED A DIVISION OF PFIZER CANADA ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGCancelled Pre Market
02429403MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGCancelled Pre Market
02429381MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 60 MGCancelled Pre Market
02429373MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGCancelled Pre Market
02429365MYLAN-ZIPRASIDONEMYLAN PHARMACEUTICALS ULCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGCancelled Pre Market
02478803PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 20 MGCancelled Pre Market
02478811PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 40 MGCancelled Pre Market
02478846PMS-ZIPRASIDONEPHARMASCIENCE INCCapsuleZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) 80 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
326572024-02-06Abbreviated New Drug Submission (ANDS)Administrative: Change in Product Ownership
219702019-03-14Abbreviated New Drug Submission (ANDS)CHANGE IN PRODUCT OWNERSHIP
216662018-12-28Abbreviated New Drug Submission (ANDS)
Request a quote for PMS-ZIPRASIDONE

How to read a Canadian DIN record